Bristol - US Politics

WASHINGTON (Reuters) - A U.S. House of Representatives committee voted on Friday to ban deals in which drug companies pay generic firms to delay bringing out a cheaper, copycat version of a drug.The House Energy and Commerce Committee, by a voice vote, ...